Template:Epidural Abscess Treatment: Difference between revisions

(Created page with "*Antibiotics target Stap, Strep, and Gram-negative bacilli<ref>Rigamonti D. et al. Spinal epidural abscess:...")
 
No edit summary
Line 1: Line 1:
*[[Antibiotics]] target [[Staphylococcus_Species|Stap]], [[Strep_Species|Strep]], and [[Gram_Negatives|Gram-negative bacilli]]<ref>Rigamonti D. et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 1999; 52:189-96</ref>
 
**[[Vanco]] 15-20mg/kg BID + [[metronidazole]] 500g (7.5mg/kg) q6 hrs + ([[cefotaxime]] or [[ceftriaxone]] or [[ceftazidime]])
*Target [[Staphylococcus_Species|Stap]], [[Strep_Species|Strep]], and [[Gram_Negatives|Gram-negative bacilli]]<ref>Rigamonti D. et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 1999; 52:189-96</ref>
***[[Ceftazidime]] is preferred if [[pseudomonas]] is considered likely
*[[Vancomycin]] 15-20mg/kg BID + [[metronidazole]] 500g (7.5mg/kg) q6 hrs + ([[Cefotaxime]] or [[Ceftriaxone]] or [[Ceftazidime]])
***Can substitute [[nafcillin]] or [[oxacillin]] for [[vanco]] if not [[MRSA]]  
**[[Ceftazidime]] is preferred if [[pseudomonas]] is considered likely
***Can substitute [[Nafcillin]] or [[Oxacillin]] for [[Vancomycin]] if not [[MRSA]]  
**Treat for 6-8 weeks
**Treat for 6-8 weeks

Revision as of 00:44, 7 April 2015

  1. Rigamonti D. et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 1999; 52:189-96